KAI MedTech

About Us

Founded in 2019, Kai MedTech Group is focused on development, production, marketing and sales of vascular intervention medical devices. Via its strong internal R&D capacities, global innovation BD resources, and complete research-production-marketing closed-loop system, Kai MedTech commits to become the leading technology platform worldwide in vascular device industry. 

Kai MedTech is one of the few players in China who has managed the solid base technology in neurovascular intervention, completed the internal production system and is capable of successful overseas business.

Quality & Regulatory Compliance

Kai MedTech has developed a thorough understanding of the complex regulatory environment. We design and manufacture components and finished devices in full compliance with US FDA, European MDR and China NMPA guidelines. Our manufacturing facilities are ISO 13485 certified.



Jan 2023

Tarvos Microguidewire and Juewa RX Balloon Dilation Catheter approved in China. 


Jan 2022

  • Funding 200+ Millions RMB in B+ Round

Aug 2021

  • Funding of 100 Millions RMB in B-Round

June 2021

  • First Class III Device NMPA Registration
  • Complete the setup of the core team and management team
  • Complete the setup of  base technology platform
  • Ongoing development of 20+ Products
  • Investments in overseas startups

June 2020       Funding of 100 millions RMB in A-Round


July 2019              Company starts operation;

May 2019              Funding of tens of millions RMB in Pre-A Round;

January 2019     Company Establishment


An Liu, Founder & CEO
  • A serial entrepreneur achieves from 0 to 1, from 1 to more in many companies.
  • Complete China licensing of Penumbra and reach 100 million RMB revenue at the first year with Hua MedTech (acquired by Genesis) 
  • Former general manager of the global largest CRO NAMSA China and Asia Pacific 
  • Former technology management in Medtronic USA and 3M USA 
Joshua Benjamin, CTO
  • 20-year R&D Experiences in aspiration catheters, stents, guidings, balloons, devices in mechanical thrombectomy & mitral valve surgery
  • Former R&D Director & First Engineer in Lombard Medical, Inc.
  • Former R&D Manager, First Engineer in MindFrame, Inc 
  • Former R&D Manager in Endologix, Inc.
  • Former Engineer in Arbor Surgical, Inc. ; 
  • Former Sr. R&D Manager Edwards Lifesciences.

Jianhua Hao, R&D Director of Hangzhou Branch
  • Former R&D Director of Vascular Invention Products in Terumo China
  • Former R&D Director in HuiKang Medical for team setup, R&D strategy and operation management;
  • Years of R&D Management Experiences in Balloons, Catheters, & Guidewires

Chao Xu, Ph.D, Director of International Business

  • PhD. in Medical Neurosciences, Berlin Charité
  • 10-year industry experiences in R&D, regulatory, clinical and business strategy
  • Setup J MedTec Berlin GmbH & OSMUNDA Group Europe Branch and develop international business from zero
  • China Industry Expert for Medical Device Daily Reuters, Lecturer of CAS Master Program of Switzerland FHNW University

Matt Liu, R&D Director of Shanghai Branch
  • Duo Master Degrees in Material & Chemistry in Tsinghua University & Tokyo Institute of Technology
  • Years of R&D Management Experiences in Stents and Guidewires
  • Former R&D Director in MicroPort
Rudy Zhao, Director, Strategy & Investment
  • Former VP of Jinyangzi Group for External Investment
  • Former Project Manager of Pan-China Certified Public Accountants (PCCPA) for audit & due-diligence
  • Former VIP account manager, Shanghai Citibank
  • Former sales in CR Double-Crane Pharma

Company Culture

  • Collaborative
  • Inclusive
  • Passionate
  • Dedicated